Online citations, reference lists, and bibliographies.
← Back to Search

Early Infections In Kidney, Heart, And Liver Transplant Recipients On Cyclosporine.

J. Dummer, A. Hardy, A. Poorsattar, M. Ho
Published 1983 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Eighty-one renal, seventeen heart, and twenty-four liver transplant patients were followed for infection. Seventeen renal patients received azathioprine (Aza) and prednisone as part of a randomized trial of immunosuppression with 21 cyclosporine-and-prednisone-treated renal transplant patients. All others received cyclosporine and prednisone. The randomized Aza patients had more overall infections (P less than 0.05) and more nonviral infections (P less than 0.02) than the randomized cyclosporine patients. Heart and liver patients had more infections than cyclosporine renal patients but fewer infections than the Aza renal patients. There were no infectious deaths in renal transplant patients on cyclosporine or Aza, but infection played a major role in 3 out of 6 cardiac transplant deaths and in 8 out of 9 liver transplant deaths. Renal patients on cyclosporine had the fewest bacteremias. Analysis of site of infection showed a preponderance of abdominal infections in liver patients, intrathoracic infections in heart patients, and urinary tract infections in renal patients. Pulmonary infections were less common in cyclosporine-treated renal patients than in Aza-treated patients (P less than 0.05). Aza patients had significantly more staphylococcal infections than all other transplant groups (P less than 0.005), and systemic fungal infections occurred only in the liver transplant group. Cytomegalovirus (CMV) shedding or serological rises in antibody titer, or both occurred in 78% of cyclosporine patients and 76% of Aza patients. Of the cyclosporine patients, 15% had symptoms related to CMV infection. Serological evidence for Epstein Barr Virus infection was found in 20% of 65 cyclosporine patients studied. Three had associated symptoms, and one developed a lymphoma.
This paper references

This paper is referenced by
Subject Review Pulmonary Aspects of Chronic Liver Disease and Liver Transplantation
Michael J. Krovvka (1985)
Temporal patterns of immunoblot‐reactive antibodies to cytomegalovirus in transplant recipients
P. Rautenberg (1992)
Herpes Simplex and Varicella Zoster Viruses: Forgotten but Not Gone
G. Miller (2007)
Effects of cyclosporin A on the splenic tissue of rats: a histomorphometric analysis.
O. A. Armas (1989)
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.
N. Singh (1988)
Ulcus gástrico por citomegalovirus en un paciente con artritis reumatoide
A. M. Cristóbal (2001)
Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation.
D. Shaffer (1987)
Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double‐blind, placebo‐controlled, multicenter trial
M. Primignani (1995)
Fatal cytomegalovirus myocarditis in a seronegative ALL patient
N. Adachi (1995)
The impact of the different severe infections on the outcome of liver transplantation. A study of 150 patients.
N. Mora (1992)
The importance of cytomegalovirus in heart-lung transplant recipients.
J. Hutter (1989)
Infectious complications of pediatric liver transplantation.
D. Saint-Vil (1991)
The effect of surgical site infections on outcomes and resource utilization after liver transplantation.
C. Hollenbeak (2001)
Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.
A. M. Hardy (1984)
Fungal Infections in the Immunocompromised Host
H. Chmel (1993)
OKT3 and viral disease in pediatric liver transplant recipients.
James S Bowman (1991)
Liposomales Amphotericin B (Ambisome®): Erste Ergebnisse zur Behandlung lebensbedrohlicher, systemischer Mykosen
E. Kuse (1991)
Pulmonary considerations of organ transplantation. Part 3.
N. Ettinger (1991)
Hepatic transplantation and biliary atresia: Early experience in eight patients
N. Ascher (2005)
Life in the allogeneic environment after lung transplantation
I. Paradis (2007)
A prospective study on infection with cytomegalovirus in renal allograft recipients immunosuppressed with cyclosporine A and low dose prednisone.
J. Arnfred (1987)
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
P. Linden (2000)
Incidence and significance of Aspergillus cultures following liver and kidney transplantation.
R. Brown (1996)
Cytomegalovirus in abdominal organ transplant recipients
Daniella Floru (2002)
Medical Aspects of Liver Transplantation
D. V. van Thiel (1984)
Shattuck lecture--allocating scarce medical resources and the availability of organ transplantation. Some moral presuppositions.
Engelhardt Ht (1984)
Prevalence of Invasive Cytomegalovirus Disease with Administration of Muromonab Cd-3 in Patients Undergoing Orthotopic Liver Transplantation
M. Hooks (1992)
Clinical Analysis of Infections Following Cardiac Transplantation
J. Park (2001)
OKT 3 and viral disease in pediatric liver transplant recipients
L. Bowman (2010)
Effect of cyclosporin A on murine experimental salmonellosis.
S. Muthukkumar (1988)
95 – Infections in Solid Organ Transplant Recipients
M. Green (2018)
Bacterial infection after liver transplantation.
S. Kim (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar